PT G20210A, factors V G1691A and 1299 His-Arg mutations and tamoxifen-associated thromboembolism in patients with breast cancer

被引：7
|
作者：
Eroglu, A
Çam, R
Yildiz, Z
Akar, N
机构：
[1] Ankara Univ, Sch Med, Breast Surg Unit, Dept Gen Surg, Ankara, Turkey
[2] Ankara Univ, Sch Med, Dept Pediat Mol Genet, Ankara, Turkey
来源：
THROMBOSIS RESEARCH | 2003年 / 111卷 / 4-5期
关键词：
D O I：
10.1016/j.thromres.2003.09.011
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：317 / 319
页数：3
相关论文
共 50 条
  • [31] Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients
    Yasa, Mehmet Hadi
    Bolaman, Zahit
    Yukselen, Vahit
    Kadikoylu, Gurhan
    Karaoglu, Ali Onder
    Batun, Sabri
    [J]. HEPATO-GASTROENTEROLOGY, 2007, 54 (77) : 1438 - 1442
  • [32] FVL G1691A and PT G20210A genes mutation and family history of thrombosis in Georgian myocardial infarction and ischemic stroke patients
    Koridze, M.
    Garakanidze, S.
    Costa, E.
    Bronze Rocha, E.
    Santos Silva, A.
    Nakashidze, I.
    Nikolaishvili, G.
    Khukhunaishvili, R.
    Kalandia, A.
    Glonti, S.
    Kakauridze, N.
    Ahmad, S.
    [J]. JOURNAL OF BIOTECHNOLOGY, 2019, 305 : S86 - S87
  • [33] Utility of thrombin-generation assay in the screening of factor V G1691A (Leiden) and prothrombin G20210A mutations and protein S deficiency
    Hézard, N
    Bouaziz-Borgi, L
    Remy, MG
    Nguyen, P
    [J]. CLINICAL CHEMISTRY, 2006, 52 (04) : 665 - 670
  • [34] Factor V Leiden and PT G20210A mutations in cancer patients with and without venous thrombosis
    Eroglu, A
    Kurtman, C
    Ulu, A
    Çam, R
    Akar, N
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (06) : 1323 - 1324
  • [35] The prevalence of factor V Leiden (G1691A), prothrombin G20210A and methylenetetrahydrofolate reductase C677T mutations in Jordanian patients with β-thalassemia major
    Al-Sweedan, Suleimman A.
    Jaradat, Said
    Iraqi, Muna
    Beshtawi, Mohamed
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2009, 20 (08) : 675 - 678
  • [36] Factor V G1691A and prothrombin G20210A in angiographically documented coronary artery disease patients with and without type 2 diabetes mellitus
    Rahimi, Z.
    Mozafari, H.
    Rezaei, M.
    Nagel, R. I.
    Muniz, A.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 354 - 355
  • [37] The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene
    Lindmarker, P
    Schulman, S
    Sten-Linder, M
    Wiman, B
    Egberg, N
    Johnsson, H
    [J]. THROMBOSIS AND HAEMOSTASIS, 1999, 81 (05) : 684 - 689
  • [38] Influence of the factor II G20210A variant or the factor V G1691A mutation on symptomatic recurrent venous thromboembolism in children: an international multicenter cohort study
    Young, G.
    Becker, S.
    Duering, C.
    Friedrichs, F.
    Goldenberg, N.
    Kenet, G.
    Manco-Johnson, M.
    Scheffold, C.
    Nowak-Goettl, U.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (01) : 72 - 79
  • [39] Prevalence of two thrombophilia predisposing mutations: Factor V G1691A (R506Q; Leiden) and prothrombin G20210A, among healthy Lebanese
    Tamim, H
    Finan, RR
    Almawi, WY
    [J]. THROMBOSIS AND HAEMOSTASIS, 2002, 88 (04) : 691 - 692
  • [40] Factor V Leiden G1691A, Prothrombin G20210A, and MTHFR C677T Mutations among Sudanese Women with Recurrent Pregnancy Loss
    Babker, Asaad Ma
    Dafallah, Sarah Elsiddig
    Mohamedahmed, Khalid Abdelsamea
    Elshaikh, Rabab Hassan
    Suliman, Rania Saad
    Elzubair, Qubaa Ahmed
    Hussein, Sanaa Efatih
    Elzaki, Salaheldein G.
    [J]. INTERNATIONAL JOURNAL OF BIOMEDICINE, 2024, 14 (01) : 59 - 65
12345